Post-COVID-19 Vaccine Parosmia: A Case Report

We present the case of a healthy 38-year-old male who developed parosmia following a second dose of AstraZeneca with a negative nasal swab of coronavirus disease 2019 (COVID-19) infection. The patient noted parosmia that started suddenly after one week of receiving the second dose of AstraZeneca wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamzami, Osama S, Kabli, Abdulrahman F, Alhothali, Ammar S, Alhothali, Omar S, Alharbi, Tayil A, Bahakim, Abdullah K, Marglani, Osama A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747983/
https://www.ncbi.nlm.nih.gov/pubmed/35028203
http://dx.doi.org/10.7759/cureus.20292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747983/
https://www.ncbi.nlm.nih.gov/pubmed/35028203
http://dx.doi.org/10.7759/cureus.20292

Ejemplares similares